Cintas (CTAS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Jan, 2026Executive summary
Achieved record quarterly revenue of $2.8 billion, up 9.3% year-over-year, with organic growth of 8.6%.
Net income rose 10.4% to $495.3 million, and diluted EPS increased 11% to $1.21.
All business segments contributed to growth, with operating margin reaching an all-time high of 23.4%.
Growth was driven by new business, increased product penetration, price increases, and strong customer retention.
Retention rates reached all-time highs, supported by superior service, expanded offerings, and a strong company culture.
Financial highlights
Operating income increased 10.9% to $655.7 million, with margin at 23.4%.
Gross margin improved to 50.4%, up 60 basis points year-over-year.
Free cash flow for the quarter was $425 million, and for the first six months was $737.5 million.
Diluted EPS for the six-month period was $2.41, up 10% from the prior year.
Net income margin for the quarter was 17.7%.
Outlook and guidance
Fiscal 2026 revenue guidance raised to $11.15–$11.22 billion, representing 7.8%–8.5% growth.
Diluted EPS guidance increased to $4.81–$4.88, a 9.3%–10.9% growth rate.
Guidance assumes constant FX, no future acquisitions, and a 20% effective tax rate.
Management expects cash flows from operating activities to remain sufficient for liquidity needs and strategic objectives.
Interest expense projected to rise due to refinancing and buyback activity.
Latest events from Cintas
- Record revenue, margin expansion, raised guidance, and UniFirst acquisition highlight strong results.CTAS
Q3 202625 Mar 2026 - $5.5B merger delivers $375M synergies, $310/share for UniFirst, closing in H2 2026.CTAS
M&A announcement11 Mar 2026 - Record growth, margin expansion, and a four-for-one stock split highlight strong 2025 outlook.CTAS
Q4 20243 Feb 2026 - Revenue and profit surged, margins expanded, and guidance was raised for fiscal 2025.CTAS
Q1 202520 Jan 2026 - Directors and key proposals were voted on, with all board and management recommendations approved.CTAS
AGM 202418 Jan 2026 - Revenue and net income surged with margin gains and higher full-year guidance.CTAS
Q2 202510 Jan 2026 - Q3 revenue and EPS surged, driving higher guidance and strong margin expansion.CTAS
Q3 20256 Jan 2026 - Directors, executive pay, and auditors approved; special meeting proposal rejected; growth plans highlighted.CTAS
AGM 202514 Dec 2025 - Annual meeting covers director elections, pay, equity plan, auditor, and key ESG shareholder proposals.CTAS
Proxy Filing1 Dec 2025